SCHEMBL22020875

SCHEMBL22020875

CCCC(C)(C)n1cc(C)c(=O)[nH]c1=O

nearest known ligand 0.41

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
▸ MAPK1 P28482 1/20 0.41
▸ TK1 P04183 7/20 0.40
▸ HPGD P15428 1/20 0.40
▸ TK2 O00142 2/20 0.36
▸ TYMP P19971 2/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ LMNA P02545 1/20 0.35
▸ ALB P02768 1/20 0.35
▸ POLB P06746 1/20 0.35
▸ ADRA1A P35348 1/20 0.35
▸ BLM P54132 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22666437 0.88 TK1 (0.49) MAPK1TK1HPGDTK2ALDH1A1
SCHEMBL26793575 0.87 MAPK1 (0.41) MAPK1TK1HPGDTK2TYMP
SCHEMBL20222500 0.86 MAPK1 (0.42) MAPK1TK1HPGDTK2TYMP
SCHEMBL22198654 0.84 TK1 (0.39) MAPK1TK1HPGDTK2TYMP
SCHEMBL21090689 0.84 TK1 (0.39) MAPK1TK1HPGDTK2TYMP
SCHEMBL25824415 0.82 DAO (0.37) ALDH1A1LMNA
SCHEMBL22260568 0.81 TK1 (0.43) MAPK1TK1HPGDTK2
SCHEMBL9910660 0.80 MAPK1 (0.44) MAPK1TK1HPGDTK2TYMP
SCHEMBL22946803 0.80 TK1 (0.47) MAPK1TK1HPGDTK2ALDH1A1
SCHEMBL22260407 0.79 MAPK1 (0.42) MAPK1TK1HPGDTK2TYMP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240067673-A1 MODIFIED NUCLEOSIDE OR NUCLEOTIDE BGI SHENZHEN (CN) 2024-02-29 — — US disclosed
US-11739325-B2 Oligonucleotide compositions and methods thereof WAVE LIFE SCIENCES LTD. (SG) 2023-08-29 — — US disclosed
US-20230203087-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2023-06-29 — — US disclosed
US-20210032620-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF WAVE LIFE SCIENCES LTD. (SG) 2021-02-04 — — US disclosed
US-20200231620-A1 TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION WAVE LIFE SCIENCES LTD. (SG) 2020-07-23 — — US disclosed
US-20200157545-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF WAVE LIFE SCIENCES LTD. (SG) 2020-05-21 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230203087-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF RNGTT, NSUN2, ALKBH1 MAPK1 3843/4885TK1 271/4885HPGD 4632/4885
US-20200157545-A1 OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF RNASE1, RNASEH1, RNASEL MAPK1 4321/4885TK1 334/4885HPGD 4653/4885
US-20200231620-A1 TECHNOLOGIES FOR OLIGONUCLEOTIDE PREPARATION POLRMT, DCLRE1B, RNGTT MAPK1 4645/4885TK1 394/4885HPGD 4878/4885
US-20240067673-A1 MODIFIED NUCLEOSIDE OR NUCLEOTIDE NT5C3B, NT5E, NT5C2 MAPK1 2110/4885TK1 67/4885HPGD 2512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback